Close mobile menu×
Close mobile menu

Chin Hur, MD, MPH

Board Certifications: 
Gastroenterology, Internal Medicine
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Gastroenterology
  • Internal Medicine

Clinical Expertise

  • Stomach Cancer
  • Gastric Cancer
  • Family History of Gastric Cancer
  • Esophageal Cancer
  • Family History of Esophageal Cancer
  • Barrett's Esophagus
  • Eosinophilic Esophagitis
  • GERD (Gastroesophageal Reflux Disease)

Education & Training

  • Johns Hopkins University School of Medicine
  • Residency: Johns Hopkins Hospital
  • Fellowship: Beth Israel Deaconess Medical Center

About Chin Hur

Dr. Chin Hur is both a physician and a research scientist. He is a recognized expert in cancer screening and prevention for gastrointestinal cancers and is a leader within a National Cancer Institute consortium of reseachers that work towards improving cancer management.

Dr. Hur has seen thousands of patients for both clinic visits and endoscopy for cancer screening and disease monitoring. He is fully committed to providing the best care possible to each patient he sees as well as improving cancer screening and prevention through his research.

His clinical and research interests keep him fully abreast of the latest technologies and improvements to patient management thereby letting him provide the most up to date care for his patients.

Academic Titles

  • Professor of Medicine

Administrative Positions

  • Director, Healthcare Innovations Research and Evaluation

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • NYP Employee Plan
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
161 Fort Washington Avenue
New York, New York 10032
Primary

Research

I am a practicing gastroenterologist and a cancer health outcomes researcher. I am a physician scientist and a Professor of Medicine and Epidemiology at Columbia University and co-leader of the Prevention, Control, and Disparities Program for the Herbert Irving Comprehensive Cancer Center at Columbia. Since 2010, I have served on the NCI’s Cancer Intervention and Surveillance Modeling Network (CISNET) steering committee. Many of our modeling analyses have made significant contributions to inform clinical and public policy guidelines.  I have experience in simulation modeling related to gastrointestinal cancers and also in many other areas such as outcomes and cost-effectiveness analyses that help test clinical management strategies in celiac disease. The overarching goal of my research as a physician-scientist is to improve clinical care for patients with cancer and to improve cancer control on a population level. I propose to achieve this goal by performing analyses that leverage the diverse health outcomes methods and techniques that my research team and I have gained expertise in.

Grants

IMPLEMENTATION OF CHILDHOOD OBESITY TREATMENT INNOVATIONS TO IMPROVE OUTCOMES OF LOW-INCOME CHILDREN: THE CONNECT FOR HEALTH II STUDY (Federal Gov)

Jul 1 2019 - Jun 30 2024

OPTIMIZING THE TREATMENT OF PANCREATIC ADENOCARCINOMA (Federal Gov)

Aug 1 2017 - Jul 31 2022

CONTROLLING ESOPHAGEAL CANCER: A COLLABORATIVE MODELING APPROACH (Federal Gov)

Jul 1 2018 - Jul 31 2021

HIGH RESOLUTION MICROENDOSCOPY FOR THE MANAGEMENT OF ESOPHAGEAL NEOPLASIA (Federal Gov)

Sep 1 2019 - Aug 31 2020

IMPROVING ESOPHAGEAL ADENOCARCINOMA PREVENTION, SCREENING AND TREATMENT (Federal Gov)

Jul 1 2018 - Mar 31 2020

PRE-HOSPITAL TRIAGE DECISIONS FOR PATIENTS WITH SUSPECTED STROKE DUE TO LARGE VESSEL OCCLUSION: A DECISION ANALYTIC MODELING COSTEFFECTIVENESS STUDY (Private)

Nov 1 2018 - Sep 1 2019

PANCREATIC CANCER SCREENING: DEVELOPMENT OF A SIMULATION MODEL (Private)

Jul 1 2018 - Jun 30 2019

A PERSONALIZED SURVEILLANCE PROGRAM FOR HEPATOCELLULAR CARCINOMA (Private)

Jul 1 2018 - Jun 30 2019

CANCER CENTER SUPPORT GRANT (Federal Gov)

Jul 1 2014 - Jun 30 2019

Selected Publications

Jang SR, Truong H, Oh A, Choi J, Tramontano AC, Laszkowska M, Hur C. Cost-effectiveness Evaluation of Targeted Surgical and Endoscopic Therapies for Early Colorectal Adenocarcinoma Based on Biomarker Profiles.JAMA Netw Open. 2020 Mar 2;3(3):e1919963. doi: 10.1001/jamanetworkopen.2019.19963. PMID: 32150269

Laszkowska M, Oh A, Hur C. Screening for Upper Gastrointestinal Malignancies in the United States—Which Immigrant Groups Should Be Considered High-Risk? Gastroenterology. 2020 Jan;158(1):4-8. doi: 10.1053/j.gastro.2019.09.047. PMID: 31614125

Chu JN, Choi J, Ostvar S, Torchia JA, Reynolds KL, Tramontano A, Gainor JF, Chung DC, Clark JW, Hur C. Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer. Cancer. 2019 Jan 15;125(2):278-289. PMID: 30343509